PTC Therapeutics
PTCT
PTCT
201 hedge funds and large institutions have $2.93B invested in PTC Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 69 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 69
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.63% less ownership
Funds ownership: 104.08% → 102.46% (-1.6%)
Holders
201
Holding in Top 10
4
Calls
$5.68M
Puts
$2.51M
Top Buyers
| 1 | +$20.4M | |
| 2 | +$10.1M | |
| 3 | +$9.81M | |
| 4 |
BlackRock
New York
|
+$7.83M |
| 5 |
Squarepoint
New York
|
+$7.75M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$15.5M | |
| 3 | -$13.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.7M |
| 5 |
Renaissance Technologies
New York
|
-$10.4M |